China Clinical Trial Supply & Logistics Market Size & Outlook
Related Markets
China clinical trial supply & logistics market highlights
- The China clinical trial supply & logistics market generated a revenue of USD 171.7 million in 2023 and is expected to reach USD 296.7 million by 2030.
- The China market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, logistics & distribution was the largest revenue generating service in 2023.
- Logistics & distribution is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial supply & logistics market data book summary
| Market revenue in 2023 | USD 171.7 million |
| Market revenue in 2030 | USD 296.7 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Logistics & distribution |
| Fastest growing segment | Logistics & distribution |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
| Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
Other key industry trends
- In terms of revenue, China accounted for 4.5% of the global clinical trial supply & logistics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China clinical trial supply & logistics market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 281.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supply & Logistics Market Scope
Clinical Trial Supply & Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Walden Group | View profile | 1001-5000 | Paris, Ile-de-France, France, Europe | http://www.walden-group.com/ |
| UDG Healthcare | View profile | 5001-10000 | Dublin, Dublin, Ireland, Europe | http://udghealthcare.com |
| Marken | View profile | 501-1000 | Durham, North Carolina, United States, North America | https://www.marken.com/ |
| PCI Pharma Services | View profile | 1001-5000 | Philadelphia, Pennsylvania, United States, North America | http://www.pciservices.com |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | https://www.almacgroup.com |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| FedEx Corp | View profile | 787400 | 942 South Shady Grove Road, Memphis, TN, United States, 38120 | https://www.fedex.com |
| DHL Group | View profile | 594396 | Platz der Deutschen Post, Bonn, NW, Germany, 53250 | http://www.dpdhl.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
China clinical trial supply & logistics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.33% in 2023. Horizon Databook has segmented the China clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the lucrative markets for clinical trial supplies players owing to its diverse pool of patients and growing pharmaceutical market. Logistics and supply chain is a major challenge in the country, which is discouraging major biopharmaceutical companies from conducting trials in China.
The country accounted for 34.83% of global clinical trials conducted as of 2020 and exhibited lucrative growth in the past 3 years. The trend is driving the entry of major players such as Catalent Pharma Solutions in China, which is expected to contribute to market growth in the country.
In 2019, Catalent Pharma Solutions, a global clinical trial supplies company, opened 30,000 ft2 Shanghai clinical supply facility located in Tangzhen, which provides customers with a mainland option and supports their need for speed & efficiency in running trials in China, including additional storage capacity, faster local distribution, and service for returns & damage.
Reasons to subscribe to China clinical trial supply & logistics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China clinical trial supply & logistics market databook
-
Our clientele includes a mix of clinical trial supply & logistics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into China clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China clinical trial supply & logistics market size, by service, 2018-2030 (US$M)
China Clinical Trial Supply & Logistics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
